Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

May 13, 2021, 7:13 a.m. EDT

CDC committee recommends that Pfizer's COVID-19 shot be used in 12- to 15-year-olds

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s /zigman2/quotes/202877789/composite PFE -0.40% COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's Advisory Committee on Immunization Practices, follows a similar regulatory pathway as the original emergency-use authorization awarded in December. The expanded authorization for this age group was announced Monday by the Food and Drug Administration, the CDC committee voted Wednesday, and CDC director Dr. Rochelle Walensky signed off on the recommendation later that night. More than 60 million people in the U.S. have been immunized with the two-dose, mRNA vaccine developed by Pfizer and BioNTech SE /zigman2/quotes/214419716/composite BNTX +1.57% , according to the latest CDC data .

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 44.03
-0.18 -0.40%
Volume: 17.86M
Sept. 21, 2021 3:26p
P/E Ratio
18.83
Dividend Yield
3.55%
Market Cap
$247.82 billion
Rev. per Employee
$580,595
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 344.34
+5.33 +1.57%
Volume: 2.20M
Sept. 21, 2021 3:26p
P/E Ratio
18.16
Dividend Yield
N/A
Market Cap
$82.22 billion
Rev. per Employee
$283,276
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.